Abstract
The descriptive epidemiological characteristics of hairy cell leukemia (HCL), a rare chronic lymphoproliferative disorder, were examined by using incidence data collected from 1972 to 1987 by the Cancer Surveillance Program, the population-based cancer registry for Los Angeles County. During the study period, 208 incident cases of histologically confirmed HCL were diagnosed. HCL comprised 2% of all leukemias diagnosed in Los Angeles County during the study period. HCL risk was concentrated in white males; there were few black and Asian patients for analysis. Overall, the age-adjusted incidence rate of HCL for men (2.9/million population) was 4.8 times greater than that for women (0.6/million population). Using data from all cancer patients diagnosed during the study period, Jewish men had significantly greater risk of HCL than Protestant men (odds ratio (OR) = 3.0, P < 0.0001); there was no significant variation in risk of HCL by religion for women. For men, the OR was significantly elevated for professional and technical workers (OR = 2.1, P = 0.001); within this category of occupations, risk was significantly elevated for engineers (OR = 4.0, P = 0.0008). HCL patients were more than twice as likely to have multiple primary cancer diagnoses as other cancer patients. Since the majority of the other primary cancer diagnoses occurred prior to (>1 year) or concurrent with (≤1 year) the HCL diagnosis, this greater frequency of multiple primaries in HCL patients may be due to impaired immune function.
Footnotes
-
↵1 This work was supported by Grant CA17054 from the NIH and by Subcontract 050E-8709 with the California Public Health Foundation which is supported by the California Department of Health Services as part of its statewide cancer reporting program, mandated by Health and Safety Code Section 210 and 211.3. The ideas and opinions expressed herein are those of the author, and no endorsement of the State of California, Department of Health Services, or the California Public Health Foundation is intended or should be inferred.
-
↵2 To whom requests for reprints should be addressed, at Department of Preventive Medicine, USC School of Medicine, 1420 San Pablo St., PMB A-202, Los Angeles, CA 90033.
- Received October 12, 1989.
- Revision received March 6, 1990.
- ©1990 American Association for Cancer Research.